BuzzSparks.org

Syndax Pharmaceuticals


Cancer Therapeutics Developer

Syndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors

Founded in 2005
Homepage:
Total money raised: $35.6M

Headquarters

02451 460 Totten Pond Road
Suite 650

Waltham
Waltham
USA MA

Phone: 781.419.1400

Updated on Aug 27, 2013
Syndax Pharmaceuticals at CrunchBase
Dennis Podlesak Board Chairman
Arlene M. Morris CEO
Joanna C. Horobin President
Eckard Weber Board Observer
Artthur M. Pappas Member of Board
Past

August, 2013

Syndax Pharmaceuticals raised $26.6M in a Series B round from Domain Associates, RusnanoMedInvest, MPM Capital, and Forward Ventures

Syndax Pharmaceuticals Secures $26.6M Series B Financing    finsmes.com

March, 2010

Syndax Pharmaceuticals raised $9M in a Series A round from Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures, and Pappas Ventures

Syndax Pharmaceuticals, Inc.: Series A $9M    onbiovc.com

2005

Syndax Pharmaceuticals was founded in 2005